SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Van Trump Phillip D

(Last) (First) (Middle)
C/O DANIMER SCIENTIFIC, INC.
140 INDUSTRIAL BOULEVARD

(Street)
BAINBRIDGE GA 39817

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Danimer Scientific, Inc. [ DNMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CSTO
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock ("Common Stock") 03/10/2021 A(1)(2)(3) 377,259 A $0 400,153 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Comprised of a restricted stock award (the "RSA") granted under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan") consisting of 377,259 restricted shares of the Common Stock (the "Restricted Shares").
2. Under the RSA, the Restricted Shares shall vest as follows: (i) one-sixth of the Restricted Shares shall vest on December 29, 2021 (the "First Time Vesting Date"); (ii) one-sixth of the Restricted Shares shall vest on December 29, 2022 (the "Second Time Vesting Date"); (iii) one-sixth of the Restricted Shares shall vest on December 29, 2023 (the "Third Time Vesting Date"); (iv) one-sixth of the Restricted Shares shall vest if the volume weighted average trading price (the "VWAP") of a share of Common Stock equals or exceeds $24.20 for any 20 trading dates within a 30 day trading period beginning on the First Time Vesting Date and ending on December 29, 2030;
3. Continuation of footnote (2): (v) one-sixth of the Restricted Shares shall vest if the VWAP of a share of Common Stock equals or exceeds $24.20 for any 20 trading dates within a 30 day trading period beginning on the Second Time Vesting Date and ending on December 29, 2030; and (vi) one-sixth of the Restricted Shares shall vest if the VWAP of a share of Common Stock equals or exceeds $24.20 for any 20 trading dates within a 30 day trading period beginning on the Third Time Vesting Date and ending on December 29, 2030.
/s/ Phillip Van Trump 03/12/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.